Composition comprising VLP and amyloid-beta peptide

Details for Australian Patent Application No. 2005300692 (hide)

Owner Novartis AG

Inventors Graf, Ana; Blattler, Thomas; Staufenbiel, Matthias; Paganetti, Paolo

Agent Davies Collison Cave

Pub. Number AU-A-2005300692

PCT Pub. Number WO2006/048295

Priority 0424563.5 05.11.04 GB

Filing date 3 November 2005

Wipo publication date 11 May 2006

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/048295 Priority application(s): WO2006/048295

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005300693-Organic compounds

2005300691-Combinations of nicotinic acetylcholine alpha 7 receptor agonists